Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE)

(1)
Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE) image
ISBN-10:

0132352060

ISBN-13:

9780132352062

Released: Jan 01, 2008
Publisher: PRENTICE/HALL
Format: Paperback, 1769 pages

Description:

A standard resource for nurses, this drug guide provides safe, effective, current, and accurate drug information in a quickly accessible format. This retail edition includes the suggested list price printed on the back cover. Includes new added dosage requirements for Obese patients and those undergoing dialysis. Comprehensive and complete, all drugs are listed alphabetically by generic names for quick referral, with an index that includes both generic and trade names. Provides users withaccess to a free PDA Download of the drug guide, along with a premium website with the entire drug database online. Nursing professionals and students.

Best prices to buy, sell, or rent ISBN 9780132352062




Related Books

Frequently Asked Questions about Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE)

You can buy the Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE) book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $8.33 on Amazon and is available from 3 sellers at the moment.

If you’re interested in selling back the Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE) book, the best buyback offer comes from and is $ for the book in good condition.

The Prentice Hall Nurse's Drug Guide 2008 (NURSING DRUG GUIDE) book is in very low demand now as the rank for the book is 11,667,194 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.